Genomic and Transcriptomic Characterization of Natural Killer T Cell LymphomaJie Xiong, Weili Zhao, Chao‐Fu Wang et al.|Cancer Cell|2020Cited by 234
Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemiaQi Qu, Depei Wu, Limin Liu et al.|Leukemia Research|2015Cited by 12